Navigation Links
Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs
Date:1/10/2012

chizophrenia, bipolar disease and depression) as well as all other antihistamines, opioids, alpha and beta blockers, serotonergics and dopaminergics. 

The industry focuses its GPCR drug discovery efforts mostly on non-sensory GPCRs. Of the 363 total non-sensory GPCRs, approximately 240 have known ligands (molecules that bind the receptors) with nearly half of those targeted either by marketed drugs (46 GPCRs) or by drugs in development (about 70 GPCRs). There are approximately 120 GPCRs with no known ligands, which are termed "orphan GPCRs." Without a known ligand, drug development for a given receptor is extremely difficult.

Omeros uses its proprietary high-throughput CRA to identify small-molecule agonists and antagonists for orphan GPCRs, unlocking them to drug development. Omeros believes that it is the first to possess the capability to unlock orphan GPCRs in high-throughput, and that currently there is no other comparable technology. Unlocking these receptors could lead to the development of drugs that act at these new targets. There is a broad range of indications linked to orphan GPCRs including cardiovascular disease, asthma, diabetes, pain, obesity, Alzheimer's disease, Parkinson's disease, multiple sclerosis, schizophrenia, learning and cognitive disorders, autism, osteoporosis, osteoarthritis and several forms of cancer.

About Omeros Corporation

Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has four ongoing clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a l
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Omeros Announces It Has Unlocked Over 20 Percent of Class A Orphan GPCRs
2. Omeros to Present at Rodman and Renshaw 13th Annual Healthcare Conference
3. Omeros to Present at Two Upcoming Conferences
4. Omeros to Present at Future Leaders in the Biotech Industry Conference
5. Omeros to Present at Needham Healthcare Conference
6. Omeros Corporation Awarded $1.7 Million in Grants Under the Qualifying Therapeutic Discovery Project Program
7. Omeros Announces Additional Support from the National Institute on Drug Abuse for Clinical Studies in Addiction Program
8. Omeros Secures $40 Million Committed Equity Financing Facility
9. Omeros To Webcast Presentation at Ninth Annual Needham Healthcare Conference
10. Omeros to Webcast Presentation at Deutsche Bank 35th Annual Health Care Conference
11. Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 1, 2014 Research and Markets ... Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Single Nucleotide Polymorphism (SNP) genotyping ... SNPs in the genome of various species. SNPs are ... and analysis technology can analyze thousands of SNPs and ...
(Date:8/1/2014)... ON (PRWEB) August 01, 2014 ... has led to a better understanding embryonic development. ... and reorganize into structurally and functionally distinct tissues ... physical defects. Prof. Todd McDevitt, Melissa Kinney, ... biophysical signals interact with biochemical cues to control ...
(Date:7/31/2014)... reason people over 60 are not donor candidates for ... with time, making the elderly prone to life-threatening infection ... team now has discovered a reason why. , "We ... of blood-forming cells to maintain blood production over time ... that could be restored for rejuvenation therapies," said Emmanuelle ...
(Date:7/31/2014)... SPRINGS, Colo. , July 31, 2014 /PRNewswire-USNewswire/ ... Grant awardee today with $25,000 to fund a ... Foundation,s inception in 2011, the gift was presented ... th Annual Meeting in Colorado ... who specialize in neurointerventional approaches to neurovascular conditions, ...
Breaking Biology Technology:Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018 2Study Links Biomechanics and Gene Expression in Stem Cells 2Key to aging immune system is discovered 2SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 2SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 3
... Record Revenue and Operating Income, PLYMOUTH MEETING, Pa., Aug. ... Sunstone, or the ,Company,),today announced its financial results from the ... 10Q today., Highlights -- Record revenues for ... $47.7 million -- Non-GAAP operating income ...
... enforcement officials may some day have a new ally - ... virtually all of the major threat agents that could be ... development by a team of Lawrence Livermore National Laboratory (LLNL) ... and field experiments. , In their latest advance, the team ...
... devised an inexpensive way to produce plastic sheets containing ... the sun and other sources. The technology, developed at ... the first step toward a solar energy collector that ... to convert the energy into usable electricity still need ...
Cached Biology Technology:BMP Sunstone Reports Second Quarter 2008 Financial Results 2BMP Sunstone Reports Second Quarter 2008 Financial Results 3BMP Sunstone Reports Second Quarter 2008 Financial Results 4BMP Sunstone Reports Second Quarter 2008 Financial Results 5BMP Sunstone Reports Second Quarter 2008 Financial Results 6BMP Sunstone Reports Second Quarter 2008 Financial Results 7BMP Sunstone Reports Second Quarter 2008 Financial Results 8BMP Sunstone Reports Second Quarter 2008 Financial Results 9BMP Sunstone Reports Second Quarter 2008 Financial Results 10BMP Sunstone Reports Second Quarter 2008 Financial Results 11Tests show LLNL detection instrument can monitor the air for all major terrorist threat substances 2Tests show LLNL detection instrument can monitor the air for all major terrorist threat substances 3Flexible nanoantenna arrays capture abundant solar energy 2Flexible nanoantenna arrays capture abundant solar energy 3
(Date:7/31/2014)... scientists from Spain, France, and the U.S. has ... the oldest definitive member of the tribe Omaliini ... discovery and description were made possible through the ... technique, which allows the detailed study of otherwise ... is described in the journal Annals of ...
(Date:7/31/2014)... of animal models against the highly infectious and virulent ... disease that kills approximately 30,000 Americans annually. The research ... Immunity . , In the study, the vaccine ... toxins produced by C. difficile , as well ... that mimics the human disease, after only two immunizations. ...
(Date:7/31/2014)... exposure to loud noise alters how the brain ... speech sounds, according to neuroscientists at The University ... published this week in Ear and Hearing ... noise-induced hearing loss affects the brain,s recognition of ... all corners of the population, affecting an estimated ...
Breaking Biology News(10 mins):C. difficile vaccine proves safe, 100 percent effective in animal models 2UT Dallas study reveals effect of loud noises on brain 2
... Electrical noise, like the crackle heard on AM radio when ... electronic devices. But within cells, a similar kind of biochemical ... another, according to a new study led by a UT ... professor of pharmacology, said his research and that of his ...
... asparaginase fails to help cure some children with acute ... in the bone marrow counteract the effect of that ... Hospital. , The researchers showed that mesenchymal cells ... leukemic cells by releasing large amounts of asparagine, an ...
... understanding of how tool use has evolved among primates, ... some conditions, are capable of habitually fashioning and using ... Jill Pruetz of Iowa State University and Paco Bertolani ... the journal Current Biology on February 22nd. , Chimpanzees ...
Cached Biology News:Cells use 'noise' to make cell-fate decisions 2Cells use 'noise' to make cell-fate decisions 3Leukemic cells find safe haven in bone marrow 2Leukemic cells find safe haven in bone marrow 3Chimpanzees found to use tools to hunt mammalian prey 2
Rabbit polyclonal to M13 Bacteriophage Coat Proteins ( Abpromise for all tested applications)....
Pancreatic Cell Cryopreservation Medium (2X) is intended for the cryopreservation of LT2 Immortalized Pancreatic Mesenchymal Cells (SCR013) and VIT1 Primary Pancreatic Mesenchymal Cells (SCR014)....
Naphthol Blue Black, CI 20470...
Recognizes rat Taste Receptor 2 (TR2). The immunogen shows no significant sequence homology with TR1, gustducin or other pheromone receptors....
Biology Products: